CN111689904A - Preparation method of triazole sulfur (selenium) ketone derivative - Google Patents
Preparation method of triazole sulfur (selenium) ketone derivative Download PDFInfo
- Publication number
- CN111689904A CN111689904A CN202010424474.4A CN202010424474A CN111689904A CN 111689904 A CN111689904 A CN 111689904A CN 202010424474 A CN202010424474 A CN 202010424474A CN 111689904 A CN111689904 A CN 111689904A
- Authority
- CN
- China
- Prior art keywords
- carbon
- group
- reaction
- triazole
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
Abstract
The invention belongs to the technical field of preparation of azoles sulfur (selenium) ketone derivatives, and particularly relates to a preparation method of a triazole sulfur (selenium) ketone derivative. The preparation method comprises the following specific steps: weighing one of a triazole compound, elemental sulfur or selenium and a catalyst sulfite, adding an organic solvent into a reaction vessel, injecting halogenated alkane, and reacting under heating to obtain a corresponding thioketone or selenone derivative, namely the triazole sulfur (selenium) ketone derivative. The invention provides a method for preparing azole sulfur (selenium) ketone derivatives with simple process, mild condition, low price, economy and high efficiency; the azoles sulfur (selenium) ketone derivative has excellent bactericidal and bacteriostatic activity, and has inhibitory activity on penicillium citrinum, gibberella cerealis, banana anthracnose and litchi anthracnose.
Description
The patent application of the invention is a divisional application with the application number of "CN 201810648408.8", the application date of the original application is "22.06.2018", the application number is "CN 201810648408.8", and the invention name is "an azole sulfur (selenium) ketone derivative and a preparation method and application thereof".
Technical Field
The invention belongs to the technical field of preparation of azoles sulfur (selenium) ketone derivatives, and particularly relates to a preparation method of a triazole sulfur (selenium) ketone derivative.
Background
Azole compounds such as derivatives of benzimidazole, imidazole, triazole and the like have important application in the fields of medicines and materials, and play an important role in the creation of novel efficient medicines. The compounds have the characteristics of high efficiency, low toxicity, excellent bioactivity and various structural changes, have wide application in the aspects of pesticides and medicines, and are always the hot and important points of organic chemistry research (Lanyan, organic chemistry, 2007,28(2): 210; Zhang Ying, pesticide, 2008,47(3), 164-. Azole drug molecules or drug intermediates are directly converted into azole thioketone derivatives, so that a novel candidate drug molecule library can be quickly constructed, and the method has important application value for screening novel drugs. Azolylthione compounds also have excellent biological activity, for example, N-methylimidazolthione is a very good anti-goiter drug (chem. Eur. J.,2010,16(4): 1175-735; J. Med. chem.,2008,51, 7313-7317.). Furthermore, imidazolethiones are excellent organometallic mercury antidotes (chem. eur.j.,2017,23, 5696-9307; Angew. chem. int.ed.,2015,54, 9323-9327.); meanwhile, the fluorescent probe can be used for imaging and detecting hypochlorite anions in living tissues (Angew. chem. int. Ed.,2015,54(16): 4890-. The imidazolethione metal complex also shows excellent catalytic activity and has important application in the field of cross-coupling reaction (Chemical Communications,2010,46(5): 758-.
The application practice of the azolethiones shows that the difference of the substituent functional groups on the nitrogen atom of the azole ring has great influence on the function difference of the azolethiones, and the azolethiones can be respectively applied to medicines, pesticides and biological functional materials. Therefore, introduction of different functional groups on the azole ring has the high possibility of obtaining azolethione functional molecules with different application values. In view of the important functions and application values of azolethiones, it is necessary to develop a simple and efficient technical method for preparing azolethione compounds and create novel azolethione molecules. The existing reaction technology for preparing the azolethiones is generally realized by cyclization reaction of isothiocyanate or thiourea with other substrates, or is obtained by converting imidazole salt and sulfur powder under the action of strong base (Organic Letters,2014,16(21): 5788-. However, isothiocyanate with rich functional groups is difficult to obtain, and the applicability of the substrate is very limited, so that the isothiocyanate is not beneficial to obtaining thioketone compounds with various structures; the use of strong bases also has a varying degree of disruption to the functional groups, resulting in poor functional group compatibility. These deficiencies are very detrimental to the preparation of azolethione functional molecules.
In view of the shortcomings of the existing preparation technology of imidazolethione compounds, a broad-spectrum, economical and efficient reaction technology for preparing azolethione derivatives is needed to be developed; meanwhile, it is very necessary to introduce various functional groups on the azole ring in order to obtain azolylthioketone derivatives with different functional application values.
Disclosure of Invention
In order to overcome the defects and shortcomings in the prior art, the invention mainly aims to provide an azole sulfur (selenium) ketone derivative.
Another object of the present invention is to provide a method for preparing the above azole thio (seleno) one derivative.
Still another object of the present invention is to provide the use of the above-mentioned azolethi (seleno) one derivatives.
The purpose of the invention is realized by the following technical scheme:
the invention provides an azoles sulfur (selenium) ketone derivative, which comprises benzimidazolethione, imidazolethione, triazolethione and related selenium ketone derivatives, and the structural formula of the derivatives is shown as formula I, II, III, IV, V, VI, VII, VIII or IX:
in the chemical formulas I and IV, R1Can be C1-C12 alkyl or benzyl, or a group in which one or more carbon atoms of C1-C12 alkyl are substituted with one or more functional groups selected from carbon-carbon double bond, carbon-carbon triple bond, cyano, tetrahydrofuran ring, dioxolane, ether, acetoxy, ester group, benzyl or pentafluorobenzyl, or a group in which one or more hydrogen atoms of C1-C12 alkyl are substituted with one or more functional groups selected from carbon-carbon double bond, carbon-carbon triple bond, cyano, tetrahydrofuran ring, dioxolane, ether, acetoxy, ester group, benzyl or pentafluorobenzyl; r2Can be any position of a benzene ring, and can be hydrogen, methyl, methoxy, ester group, ether, amino, nitro or halogen (fluorine, chlorine, bromine, iodine); r3Can be C1-C12 alkyl or benzyl, or a group in which one or more carbon atoms of C1-C12 alkyl are substituted by more than one functional group of ester group, fluorine, carbon-carbon double bond, carbon-carbon triple bond, acetoxy or cyano, or a group in which one or more hydrogen atoms of C1-C12 alkyl are substituted by more than one functional group of ester group, fluorine, carbon-carbon double bond, carbon-carbon triple bond, acetoxy or cyano.
In the formulae II and V, R4Can be C1-C12 alkyl or benzene ring group, or a group in which one or more carbon atoms on C1-C12 alkyl are substituted by more than one functional group of methyl, fluoro-acetyl substituted phenyl, ester group or amide group, or a group in which one or more hydrogen atoms on C1-C12 alkyl are substituted by more than one functional group of methyl, fluoro-acetyl substituted phenyl, ester group or amide group; r5Can be at the 4-or 5-position of the imidazole ring, and can be hydrogen, phenyl, p-hydroxyphenyl,
(dotted line represents a connecting bond) or
(dotted line represents a connecting bond); r6The functional group can be C1-C12 alkyl, or a group in which one or more carbon atoms on the C1-C12 alkyl are substituted by more than one functional group of ester group, fluorine, carbon-carbon double bond, carbon-carbon triple bond or cyano, or a group in which one or more hydrogen atoms on the C1-C12 alkyl are substituted by more than one functional group of ester group, fluorine, carbon-carbon double bond, carbon-carbon triple bond or cyano.
In the formulae III and VI, R7Can be C1-C12 alkyl, benzyl or
(the dotted line represents a connecting bond), or a group in which one or more carbon atoms of the alkyl group of C1 to C12 are substituted with one or more functional groups selected from a carbon-carbon double bond, a carbon-carbon triple bond, a cyano group, a tetrahydrofuran ring, a dioxolane, an ether, an acetoxy group, an ester group, a benzyl group, and a pentafluorobenzyl group, or a group in which one or more hydrogen atoms of the alkyl group of C1 to C12 are substituted with one or more functional groups selected from a carbon-carbon double bond, a carbon-carbon triple bond, a cyano group, a tetrahydrofuran ring, a dioxolane, an ether, an acetoxy group, an ester group, a benzyl group, and a pentafluorobenzyl group; r8The functional group can be C1-C12 alkyl, or a group in which one or more carbon atoms on the C1-C12 alkyl are substituted by more than one functional group of ester group, fluorine, carbon-carbon double bond, carbon-carbon triple bond or cyano, or a group in which one or more hydrogen atoms on the C1-C12 alkyl are substituted by more than one functional group of ester group, fluorine, carbon-carbon double bond, carbon-carbon triple bond or cyano.
Preferably, the azole thio (seleno) one derivative is a compound shown in the following structural formula:
the present invention also provides a process for preparing the azolethione (selenone) derivatives represented by the above formulae I to IX, which comprises the following reaction route:
in the reaction formulas (1) to (9), X ═ Br or I;
in the reaction formulae (1) and (4), R1Can be C1-C12 alkyl or benzyl, or a group in which one or more carbon atoms of C1-C12 alkyl are substituted with one or more functional groups selected from carbon-carbon double bond, carbon-carbon triple bond, cyano, tetrahydrofuran ring, dioxolane, ether, acetoxy, ester group, benzyl or pentafluorobenzyl, or a group in which one or more hydrogen atoms of C1-C12 alkyl are substituted with one or more functional groups selected from carbon-carbon double bond, carbon-carbon triple bond, cyano, tetrahydrofuran ring, dioxolane, ether, acetoxy, ester group, benzyl or pentafluorobenzyl; when the ring connected in parallel with the imidazole ring is an aromatic ring, R2Can be any position of a benzene ring, and can be hydrogen, methyl, methoxy, halogen, ester group, nitro, fluorine, chlorine, bromine or iodine; in the reaction formulae (1), (4), (7), (8) and (9), R3Can be C1-C12 alkyl or benzyl, or a group in which one or more carbon atoms of C1-C12 alkyl are substituted by more than one functional group of ester group, fluorine, carbon-carbon double bond, carbon-carbon triple bond, acetoxy or cyano, or a group in which one or more hydrogen atoms of C1-C12 alkyl are substituted by more than one functional group of ester group, fluorine, carbon-carbon double bond, carbon-carbon triple bond, acetoxy or cyano.
In the reaction formulae (2) and (5), R4Can be C1-C12 alkyl or benzene ring radical, or one or more carbon atoms of C1-C12 alkylA group substituted by more than one functional group of phenyl, ester or amide substituted by methyl, fluorine acetyl, or a group substituted by more than one functional group of phenyl, ester or amide substituted by methyl, fluorine acetyl on one or more hydrogen atoms of C1-C12 alkyl; r5Can be at the 4-or 5-position of the imidazole ring, and can be hydrogen, phenyl, p-hydroxyphenyl,
(dotted line represents a connecting bond) or
(dotted line represents a connecting bond); r6The functional group can be C1-C12 alkyl, or a group in which one or more carbon atoms on the C1-C12 alkyl are substituted by more than one functional group of ester group, fluorine, carbon-carbon double bond, carbon-carbon triple bond or cyano, or a group in which one or more hydrogen atoms on the C1-C12 alkyl are substituted by more than one functional group of ester group, fluorine, carbon-carbon double bond, carbon-carbon triple bond or cyano.
In the above reaction formulae (3) and (6), R7Can be C1-C12 alkyl, benzyl or
(the dotted line represents a connecting bond), or a group in which one or more carbon atoms of the alkyl group of C1 to C12 are substituted with one or more functional groups selected from a carbon-carbon double bond, a carbon-carbon triple bond, a cyano group, a tetrahydrofuran ring, a dioxolane, an ether, an acetoxy group, an ester group, a benzyl group, and a pentafluorobenzyl group, or a group in which one or more hydrogen atoms of the alkyl group of C1 to C12 are substituted with one or more functional groups selected from a carbon-carbon double bond, a carbon-carbon triple bond, a cyano group, a tetrahydrofuran ring, a dioxolane, an ether, an acetoxy group, an ester group, a benzyl group, and a pentafluorobenzyl group; r8Can be C1-C12 alkyl, or C1-C12 alkyl group with one or more carbon atoms substituted by more than one functional group of ester group, fluorine, carbon-carbon double bond, carbon-carbon triple bond or cyano, or C1-C12 alkyl with one or more hydrogen atoms substituted by ester group, fluorine, carbon-carbon double bond, carbon-carbon triple bondOr a cyano group.
Preferably, in the reaction formulas (1) and (4), the dosage ratio (mass-mol ratio) of the compound 1, the sulfur powder or the selenium powder and the compound 2 is 1.0 (1.0-3.0) to (1.0-3.0), preferably 1.0:2.0: 2.5. In the reaction formulas (7), (8) and (9), the molar ratio of the starting compound raw material, sulfur powder or selenium powder and halogenated alkane is 1.0 (1.0-3.0) to (1.0-3.0), preferably 1.0:2.0: 2.5.
Preferably, in the reaction formulas (2) and (5), the amount ratio (mass-mol ratio) of the compound 3, the sulfur powder or the selenium powder, and the compound 4 is 1.0 (1.0-3.0) to 1.0 (1.0-3.0), preferably 1.0:2.0: 2.5.
Preferably, in the reaction formulas (3) and (6), the amount ratio (mass-mole ratio) of the compound 5, the sulfur powder or the selenium powder, and the compound 6 is 1.0 (1.0-3.0) to 1.0 (1.0-3.0), preferably 1.0:2.0: 2.5.
The reaction comprises the following specific steps: weighing an azole compound, one of elemental sulfur or selenium and a catalyst sulfite, adding an organic solvent into a reaction vessel, injecting halogenated alkane, and reacting under heating to obtain a corresponding thioketone or selenone derivative, namely the compound shown in the formula I, II, III, IV, V, VI, VII, VIII or IX.
Preferably, in the above method, the reaction solvent is a commonly used organic solvent, and specifically, may be selected from benzene, toluene, xylene, chlorobenzene, dichlorobenzene, dichloromethane, 1, 2-dichloroethane, chloroform, carbon tetrachloride, diethyl ether, diisopropyl ether, tetrahydrofuran, acetone, butanone, methyl isobutyl ketone, acetonitrile, propionitrile, butyronitrile, N-dimethylformamide, N-dimethylacetamide, N-methyl-formanilide, N-methylpyrrolidone, hexamethylphosphoric triamide, ethyl acetate, dimethyl sulfoxide, methanol, ethanol, N-propanol, isopropanol, ethylene glycol monomethyl ether and at least one of 1, 4-dioxane, preferably at least one of 1, 2-dichloroethane, tetrahydrofuran, toluene, acetonitrile and 1, 4-dioxane, with 1, 2-dichloroethane being the most preferred solvent.
Preferably, the halogenated alkane is brominated alkane or iodoalkane.
Preferably, the catalyst is sulfite, and specifically can be selected from at least one of sodium formaldehyde sulfoxylate, sodium dithionite, sodium bisulfite, sodium sulfite and sodium thiosulfate; at least one of sodium dithionite, sodium bisulfite and sodium thiosulfate is preferable.
Preferably, in the reaction step, the reaction temperature is 40-160 ℃, preferably 80-20 ℃; the reaction time is 6 to 24 hours, preferably 12 to 24 hours, and most preferably 24 hours.
The azoles sulfur (selenium) ketone derivative can be applied to the fields of pesticides, medicines, organic functional materials, transition metal delivery and fluorescent probes.
The azoles sulfur (selenium) ketone derivative has excellent bactericidal and bacteriostatic activity, and has inhibitory activity on penicillium citrinum, gibberella cerealis, banana anthracnose and litchi anthracnose.
Compared with the prior art, the invention has the following advantages and beneficial effects:
(1) the invention provides a method for preparing azole sulfur (selenium) ketone derivatives with simple process, mild condition, low price, economy and high efficiency;
(2) the compound shown in the formula I-IX provided by the invention has important potential application value in pesticides, medicines and organic functional materials.
Detailed Description
The present invention will be described in further detail with reference to examples, but the embodiments of the present invention are not limited thereto. The following examples are preferred embodiments of the present invention, but the present invention is not limited to the above examples, and any other changes, modifications, substitutions, combinations, and simplifications which do not depart from the spirit and principle of the present invention should be construed as equivalents thereof, and all such changes, modifications, substitutions, combinations, and simplifications are intended to be included in the scope of the present invention.
Example 1:
preparation of 2-fluoro-2- (3-methyl-2-thio-2, 3-dihydro-1H-benzo [ d ] s of formula I]Imidazol-1-yl) acetic acid ethyl ester compound (R)1Is methyl, R2As hydrogen):
the method comprises the following steps: 1-methylbenzimidazole (0.4mmol) and sulfur powder (S) were added to an oven-dried 15mL sealed tube equipped with a magnetic stirrer and a tetrafluoroethylene cap8) (0.8mmol), Bromofluoroacetic acid ethyl ester (1.0mmol) in Na2S2O4(0.8mmol) as a catalyst in a solution of 1, 2-Dichloroethane (DCE) (2.0mL) as a solvent was stirred at 80 ℃ for 24 hours. After the reaction was completed, the reaction mixture was cooled to room temperature, the mixture was extracted with dichloromethane, and the organic layers were combined and extracted with anhydrous Na2SO4Dry and evaporate the solvent in vacuo on a rotary evaporator. Flash column chromatography using 300-.
The second method comprises the following steps: different from the method I, the inorganic reducing agent used is sodium hydrosulfite (Na)2S2O4) Replacement with sodium bisulfite (NaHSO)3) The yield of the synthesis was 91%.
The third method comprises the following steps: different from the method I, the inorganic reducing agent used is sodium hydrosulfite (Na)2S2O4) Change to sodium thiosulfate (Na)2S2O3) The yield of the synthesis was 92%.
The method four comprises the following steps: the difference from the first method is that the amount of the raw material 1-methylbenzimidazole to be reacted was enlarged to 8mmol (1.08g), the reaction was carried out in a reaction flask equipped with a reflux condenser, and the purification process of the product after the reaction was the same as the first method, and the yield of the product was 67%.
Example 2:
preparation of ethyl 2-fluoro-2- (3-methyl-2-thio-2, 3-dihydro-1H-imidazol-1-yl) acetate compound (R) of formula II1Is benzyl, R2As hydrogen):
1-Benzylbenzimidazole (0.4mmol), Sulfur powder (S) were added to an oven-dried 15mL sealed tube with a tetrafluoroethylene cap equipped with a magnetic stirrer8) (0.8mmol), Bromofluoroacetic acid ethyl ester (1.0mmol) in Na2S2O4(0.8mmol) as a catalyst in a solution of 1, 2-Dichloroethane (DCE) (2.0mL) as a solvent was stirred at 80 ℃ for 24 hours. After the reaction was completed, the reaction mixture was cooled to room temperature, the mixture was extracted with dichloromethane, and the organic layers were combined and extracted with anhydrous Na2SO4Dry and evaporate the solvent in vacuo on a rotary evaporator. Flash column chromatography using 300-.
The second method comprises the following steps: the difference from the first method is that the amount of 1-benzylbenzimidazole as the starting material for the reaction was enlarged to 2mmol (0.396g), and the purification process of the product after the reaction was the same as the first method, and the yield of the product was 81%.
Example 3:
preparation of 1-benzyl-3-methyl-1, 3-dihydro-2H-benzo [ d ] benzene of formula I]Imidazole-2-thione compounds (R)1Is methyl, R2Is hydrogen, R3Is benzyl):
the method comprises the following steps: 1-methylbenzimidazole (0.4mmol) and sulfur powder (S) were added to an oven-dried 15mL sealed tube equipped with a magnetic stirrer and a tetrafluoroethylene cap8) (0.8mmol), benzyl bromide (1.0mmol) in Na2S2O4(0.8mmol) as a catalyst in a solution of 1, 2-Dichloroethane (DCE) (2.0mL) as a solvent was stirred at 80 ℃ for 24 hours. After the reaction was completed, the reaction mixture was cooled to room temperature, the mixture was extracted with dichloromethane, and the organic layers were combined and extracted with anhydrous Na2SO4Dry and evaporate the solvent in vacuo on a rotary evaporator. Flash column chromatography using 300-plus 400 mesh silica gelMethod, the crude mixture was purified by preparative TLC monitoring plates in (petroleum (PE): Ethyl Acetate (EA): 6:1) to give the product (I-31) as a white solid in m.p.: 134.0-135.0 ℃ with a yield of 32%.
The second method comprises the following steps: the difference from the first method is that the reaction temperature is 120 ℃ and the reaction time is 24 h. The purification process of the reacted product was the same as the first method, and the yield of the product was 95%.
Example 4:
preparation of ethyl 2-fluoro-2- (3-methyl-2-thio-2, 3-dihydro-1H-imidazol-1-yl) acetate compound (R) of formula II1Is methyl, R2As hydrogen):
an oven-dried 15mL sealed tube equipped with a magnetic stirrer and a tetrafluoroethylene cap was charged with N-methylimidazole (0.4mmol) and sulfur powder (S)8) (0.8mmol), Bromofluoroacetic acid ethyl ester (1.0mmol) in Na2S2O4(0.8mmol) as a catalyst in a solution of 1, 2-Dichloroethane (DCE) (2.0mL) as a solvent was stirred at 80 ℃ for 24 hours. After the reaction was completed, the reaction mixture was cooled to room temperature, the mixture was extracted with dichloromethane, and the organic layers were combined and extracted with anhydrous Na2SO4Dry and evaporate the solvent in vacuo on a rotary evaporator. Flash column chromatography using 300-.
Example 5:
preparation of Ethyl 2-fluoro-2- (1-methyl-5-thioxo-1, 5-dihydro-4H-1, 2, 4-triazol-4-yl) acetate (R) of formula III1Is methyl):
1-methyl triazole (0.4mmol) and sulfur powder (S) are added into a 15mL sealed tube which is provided with a magnetic stirrer and is dried by an oven with a tetrafluoroethylene cap8) (0.8mmol), Bromofluoroacetic acid ethyl ester (1.0mmol) in Na2S2O4(0.8mmol) as a catalyst in a solution of 1, 2-Dichloroethane (DCE) (2.0mL) as a solvent was stirred at 80 ℃ for 24 hours. After the reaction was completed, the reaction mixture was cooled to room temperature, the mixture was extracted with dichloromethane, and the organic layers were combined and extracted with anhydrous Na2SO4Dry and evaporate the solvent in vacuo on a rotary evaporator. Flash column chromatography using 300-.
Example 6:
preparation of 2- (6-bromo-3-methyl-2-thio-2, 3-dihydro-1H-imidazo [4,5-b ] of formula I]Pyridin-1-yl) -2-fluoroacetic acid ethyl ester (R)1Is methyl):
6-bromo-3-methyl-3H-imidazo (4,5-b) pyridine (0.4mmol), sulfur powder (S) were added to an oven-dried 15mL sealed tube with a tetrafluoroethylene cap equipped with a magnetic stirrer8) (0.8mmol), Bromofluoroacetic acid ethyl ester (1.0mmol) in Na2S2O4(0.8mmol) as a catalyst in a solution of 1, 2-Dichloroethane (DCE) (2.0mL) as a solvent was stirred at 80 ℃ for 24 hours. After the reaction was completed, the reaction mixture was cooled to room temperature, the mixture was extracted with dichloromethane, and the organic layers were combined and extracted with anhydrous Na2SO4Dry and evaporate the solvent in vacuo on a rotary evaporator. Flash column chromatography using 300-.
Example 7:
preparation of 2-fluoro-2- (1-isobutyl-2-thio-1, 2-dihydro-3H-imidazo [4, 5-c) of formula I]Quinolin-3-yl) acetic acid ethyl ester compound (R)1Is isopropyl):
the method comprises the following steps: 1-isobutyl-1H-imidazo [4,5-c ] was added to an oven-dried 15mL sealed tube with a tetrafluoroethylene cap equipped with a magnetic stirrer]Quinoline (0.4mmol), Sulfur powder (S)8) (0.8mmol), Bromofluoroacetic acid ethyl ester (1.0mmol) in Na2S2O4(0.8mmol) as a catalyst in a solution of 1, 2-Dichloroethane (DCE) (2.0mL) as a solvent was stirred at 80 ℃ for 24 hours. After the reaction was completed, the reaction mixture was cooled to room temperature, the mixture was extracted with dichloromethane, and the organic layers were combined and extracted with anhydrous Na2SO4Dry and evaporate the solvent in vacuo on a rotary evaporator. Flash column chromatography using 300-.
The second method comprises the following steps: the difference from the first method is that the reaction temperature is 100 ℃ and the reaction time is 24 h. The purification process of the reacted product is the same as the first method, and the yield of the product is 60%.
Example 8:
preparation of ethyl 2- (6- (benzylamino) -7-methyl-8-thioxo-7, 8-dihydro-9H-purin-9-yl) -2-fluoroacetate of formula I (R)1Is methyl):
N-benzyl-7-methyl-7H-purin-6-amine (0.4mmol), sulfur powder (S) were added to an oven-dried 15mL sealed tube with a tetrafluoroethylene cap equipped with a magnetic stirrer8) (0.8mmol), Bromofluoroacetic acid ethyl ester (1.0mmol) in Na2S2O4(0.8mmol) as a catalyst in a solution of 1, 2-Dichloroethane (DCE) (2.0mL) as a solvent was stirred at 100 ℃ for 24 hours. After the reaction was completed, the reaction mixture was cooled to room temperature, the mixture was extracted with dichloromethane, and the organic layers were combined and extracted with anhydrous Na2SO4Dried and placed on a rotary evaporatorThe solvent was evaporated in vacuo. Flash column chromatography using 300-.
Example 9:
preparation of ethyl-2- (3- (2- ((4-chlorobenzyl) oxy) -2- (2, 4-dichlorophenyl) ethyl) -2-thioxo-2, 3-dihydro-1H-imidazol-1-yl) -2-fluoroacetate of formula i:
the method comprises the following steps: adding econazole (0.4mmol) and sulfur powder (S) into an oven-dried 15mL sealed tube with a tetrafluoroethylene cap and a magnetic stirrer8) (0.8mmol), Bromofluoroacetic acid ethyl ester (1.0mmol) in Na2S2O4(0.8mmol) as a catalyst in a solution of 1, 2-Dichloroethane (DCE) (2.0mL) as a solvent was stirred at 80 ℃ for 24 hours. After the reaction was completed, the reaction mixture was cooled to room temperature, the mixture was extracted with dichloromethane, and the organic layers were combined and extracted with anhydrous Na2SO4Dry and evaporate the solvent in vacuo on a rotary evaporator. Flash column chromatography using 300-.
The second method comprises the following steps: the difference from the first method is that the amount of the raw material econazole reacted was enlarged to 10mmol (3.93g), and the purification process of the product after the reaction was the same as the first method, and the yield of the product was 59%. (the reaction effect can still reach more than 50 percent, and is not greatly different from a small amount of reaction effect).
Example 10:
preparation of ethyl 2- (3- (((2R, 4S) -4- ((4- (4-acetylpiperazin-1-yl) phenoxy) methyl) -2- (2, 4-dichlorophenyl) -1, 3-dioxolan-2-yl) methyl) -2-thioxo-2, 3-dihydro-1H-imidazol-1-yl) -2-fluoroacetate of formula ii:
ketoconazole (0.4mmol) and sulfur powder (S) were added to an oven-dried 15mL sealed tube equipped with a magnetic stirrer and a tetrafluoroethylene cap8) (0.8mmol), Bromofluoroacetic acid ethyl ester (1.0mmol) in Na2S2O4(0.8mmol) as a catalyst in a solution of 1, 2-Dichloroethane (DCE) (2.0mL) as a solvent was stirred at 100 ℃ for 24 hours. After the reaction was completed, the reaction mixture was cooled to room temperature, the mixture was extracted with dichloromethane, and the organic layers were combined and extracted with anhydrous Na2SO4Dry and evaporate the solvent in vacuo on a rotary evaporator. Flash column chromatography using 300-.
Example 11:
preparation of ethyl ((2- (2, 4-difluorophenyl) -2-hydroxypropan-1, 3-diyl) bis (5-thio-1, 5-dihydro-4H-1, 2, 4-triazol-2-yl) -1, 4-diyl)) bis (2-fluoroacetate) of the formula iii):
adding fluconazole (0.4mmol) and sulfur powder (S) into an oven-dried 15mL sealed tube with a tetrafluoroethylene cap and a magnetic stirrer8) (0.8mmol), Bromofluoroacetic acid ethyl ester (1.0mmol) in Na2S2O4(0.8mmol) as a catalyst in a solution of 1, 2-Dichloroethane (DCE) (2.0mL) as a solvent was stirred at 100 ℃ for 24 hours. After the reaction was completed, the reaction mixture was cooled to room temperature, the mixture was extracted with dichloromethane, and the organic layers were combined and extracted with anhydrous Na2SO4Dry and evaporate the solvent in vacuo on a rotary evaporator. Flash column chromatography using 300-.
Example 12:
preparation of 2-fluoro-2- (3-methyl-2-selenoxy-2, 3-dihydro-1H-benzo [ d ] b-phenyl]Imidazol-1-yl) acetic acid ethyl ester (R)1Is methyl, R2As hydrogen):
to an oven-dried 15mL sealed tube with a tetrafluoroethylene cap equipped with a magnetic stirrer was added N-methylbenzimidazole (0.4mmol), selenium powder (Se) (0.8mmol), ethyl bromofluoroacetate (1.0mmol) in Na2S2O4(0.8mmol) as catalyst in 1, 2-Dichloroethane (DCE) (2.0mL) was stirred at 80 ℃ for 24 hours. After the reaction was completed, the reaction mixture was cooled to room temperature, the mixture was extracted with dichloromethane, and the organic layers were combined and extracted with anhydrous Na2SO4Dry and evaporate the solvent in vacuo on a rotary evaporator. Flash column chromatography using 300-400 mesh silica gel and purification of the crude mixture by preparative TLC monitoring spot plates in (petroleum (PE): Ethyl Acetate (EA): 7:1) gave the product ((I-49), m.p.: 154.3-155.7) as a white solid in 62% yield.
Example 13:
preparing ethyl 2- (3- (2- ((4-chlorobenzyl) oxy) -2- (2, 4-dichlorophenyl) ethyl) -2-selenoxy-2, 3-dihydro-1H-imidazol-1-yl) -2-fluoroacetate of formula II:
adding econazole (0.4mmol), selenium powder (Se) (0.8mmol), ethyl bromofluoroacetate (1.0mmol) in Na in an oven-dried 15mL sealed tube with a tetrafluoroethylene cap and a magnetic stirrer2S2O4(0.8mmol) as catalyst in a solution of 1, 2-Dichloroethane (DCE) (2.0mL) as solvent and stirred at 100 ℃ for 24 h. After the reaction was completed, the reaction mixture was cooled to room temperature, the mixture was extracted with dichloromethane, and the organic layers were combined and extracted with anhydrous Na2SO4Dry and evaporate the solvent in vacuo on a rotary evaporator. The application of 300-mesh 400-mesh silica gelFlash column chromatography, monitored by preparative TLC plates in (petroleum (PE): Ethyl Acetate (EA) ═ 5:1) purified the crude mixture to give the product (II-50) as a yellow oil in 43% yield.
Example 14:
preparation of ethyl 2-fluoro-2- (1-methyl-5-selenoxy-1, 5-dihydro-4H-1, 2, 4-triazol-4-yl) acetate (R) of formula III1Is methyl):
adding 1-methyl triazole (0.4mmol), selenium powder (Se) (0.8mmol) and ethyl bromofluoroacetate (1.0mmol) in a sealed tube (15 mL) which is provided with a magnetic stirrer and is dried by an oven with a tetrafluoroethylene cap, and adding Na2S2O4(0.8mmol) as a catalyst in a solution of 1, 2-Dichloroethane (DCE) (2.0mL) as a solvent was stirred at 100 ℃ for 24 hours. After the reaction was completed, the reaction mixture was cooled to room temperature, the mixture was extracted with dichloromethane, and the organic layers were combined and extracted with anhydrous Na2SO4Dry and evaporate the solvent in vacuo on a rotary evaporator. Flash column chromatography using 300-.
Following the same procedure as in example 1, only R of the reaction formula of formula (1)1、R2And R3The substitution is carried out according to the table 2, and other corresponding products shown as the formulas I-III are obtained, and the serial numbers are (I-III) -1-51. The appearance and yield of the above compounds are shown in Table 2, and the results of infrared, low resolution and nuclear magnetic hydrogen spectroscopy are shown in Table 3. As can be seen from the above, the compounds numbered (I-III) - (1-51) in sequence have correct structures and are all compounds shown as formulas I, II or III.
Two-fold dilution method bacteriostatic activity test experiment:
(1) selecting 4 plant pathogenic fungi such as Penicillium citrinum, Gibberella tritici, Banana anthrax and litchi anthrax as test fungi. The tested fungi were activated. Selecting a small amount of strains by using an inoculating needle, and culturing the strains in a potato culture medium at 37 ℃ for 24h, wherein the colony concentration is about 10^7, and the method is suitable for the next experiment. The above penicillium citrinum and anthracnose of litchi are disclosed in the literature (Fitoterapia2017,123, 23-28). The above-mentioned gibberella tritici and banana anthrax are disclosed in the literature (proceedings of southern China university of agriculture, 2017, 38(3): 64-69).
(2) Weighing the sample, preparing into 512 mug/mL liquid medicine, and filtering with a filter membrane for standby. If the sample is not dissolved in water, 5% DMSO and 5% Tween-80 can be added to promote dissolution, and then the volumetric flask, distilled water and the like are sterilized and then the solution (suspension) is prepared in a super-clean bench.
(3) 11 small tubes were taken and 1mL of the medium was added. 1mL of the drug solution was added to the first test tube, mixed well, and then 1mL was aspirated and added to the second tube, and thus 1mL was aspirated from the tenth tube and discarded, so that the sample concentration of each tube was 200, 100, 50, … …, 0.39. mu.g/mL, and the eleventh tube was not dosed with the drug solution as a blank control. Then 20uL of the bacterial solution was added to the tubes, respectively, at a final concentration of 100, 50, 25, … …, 0.20. mu.g/mL.
(4) And (4) placing the inoculated bacterial liquid in an incubator at 37 ℃ to culture and observe the growth condition of the strains in each tube, and judging the MIC value of the strains. When the solution is a suspension, 10 μm of the bacterial solution can be uniformly spread in a solid broth culture medium, and the growth of the bacterial strain can be observed every 24h, with a period of one week.
And (3) selecting azole thione compounds I-1, II-46, III-48 and III-42 to carry out activity test, taking the eleventh tube as a reference, and obtaining an MIC value according to the change condition of hyphae in the test tube. The test results are shown in table 1 below:
TABLE 1 antimicrobial Activity test results
The results show that: the compounds I-1, II-46, III-48 and III-42 have different bacteriostatic activities on different plant pathogenic fungi, the best inhibitory effect is penicillium citrinum, the MIC value is 12.5 mu g/mL, and the novel compound has a certain bacteriostatic effect on germ interference of fruit and vegetable crops.
TABLE 2 physical constants of the compounds of formulae I-III
TABLE 3 characterization data for the compounds of formulae I-III
Claims (8)
1. The preparation method of the triazole thioketone derivative is characterized by comprising the following specific steps: weighing a triazole compound, elemental sulfur and a catalyst, adding an organic solvent into a reaction vessel, injecting a compound 6, and reacting under a heating condition to obtain a corresponding thioketone derivative, namely a compound shown in a formula III; the catalyst is at least one of sodium hydrosulfite, sodium bisulfite and sodium thiosulfate;
in the reaction formula, X ═ Br or I;
R7is C1-C12 alkyl, benzyl or
Or a C1-C12 alkyl group containing a carbon-carbon double bond, a carbon-carbon triple bond, a cyano group, a tetrahydrofuran ring, a dioxolane, an ether, an acetoxy group, an ester group, a benzyl group or a pentafluorobenzyl group;
R8is C1-C12 alkyl, or C1-C12 alkyl containing ester group and fluorineA carbon-carbon double bond, a carbon-carbon triple bond or a cyano group.
2. The method for preparing triazole thione derivatives according to claim 1, which is characterized in that,
in the reaction formula (3), the molar ratio of the compound 5, the sulfur powder and the compound 6 is 1.0 (1.0-3.0) to 1.0-3.0.
3. The method for preparing triazolinthione derivatives according to claim 1, wherein the organic solvent is at least one selected from the group consisting of benzene, toluene, xylene, chlorobenzene, dichlorobenzene, dichloromethane, 1, 2-dichloroethane, chloroform, carbon tetrachloride, diethyl ether, diisopropyl ether, tetrahydrofuran, acetone, methyl ethyl ketone, methyl isobutyl ketone, acetonitrile, propionitrile, butyronitrile, N-dimethylformamide, N-dimethylacetamide, N-methyl-formanilide, N-methylpyrrolidone, hexamethylphosphoric triamide, ethyl acetate, dimethyl sulfoxide, methanol, ethanol, N-propanol, isopropanol, ethylene glycol monomethyl ether, and 1, 4-dioxane.
4. The preparation method of the triazolinethione derivatives according to claim 1, characterized in that in the reaction step, the reaction temperature is 40-160 ℃; the reaction time is 6-24 hours.
5. The preparation method of the triazole selenone derivative is characterized by comprising the following specific steps: weighing a triazole compound, elemental selenium and a catalyst, adding an organic solvent into a reaction vessel, injecting a compound 6, and reacting under a heating condition to obtain a corresponding selenone derivative, namely the compound shown in the formula VI; the catalyst is at least one of sodium hydrosulfite, sodium bisulfite and sodium thiosulfate;
in the reaction formula, X ═ Br or I;
R7is C1-C12 alkyl, benzyl or
Or a C1-C12 alkyl group containing a carbon-carbon double bond, a carbon-carbon triple bond, a cyano group, a tetrahydrofuran ring, a dioxolane, an ether, an acetoxy group, an ester group, a benzyl group or a pentafluorobenzyl group;
R8is C1-C12 alkyl or a substituent containing ester group, fluorine, carbon-carbon double bond, carbon-carbon triple bond or cyano on C1-C12 alkyl.
6. The preparation method of triazole selenone derivatives as claimed in claim 5, characterized in that,
in the reaction formula (6), the molar ratio of the compound 5, the selenium powder and the compound 6 is 1.0 (1.0-3.0) to 1.0-3.0.
7. The method for preparing triazole selenone derivatives according to claim 5, wherein the organic solvent is at least one selected from the group consisting of benzene, toluene, xylene, chlorobenzene, dichlorobenzene, dichloromethane, 1, 2-dichloroethane, chloroform, carbon tetrachloride, diethyl ether, diisopropyl ether, tetrahydrofuran, acetone, butanone, methyl isobutyl ketone, acetonitrile, propionitrile, butyronitrile, N-dimethylformamide, N-dimethylacetamide, N-methyl-formanilide, N-methylpyrrolidone, hexamethylphosphoric triamide, ethyl acetate, dimethyl sulfoxide, methanol, ethanol, N-propanol, isopropanol, ethylene glycol monomethyl ether, and 1, 4-dioxane.
8. The preparation method of triazole selenone derivatives according to claim 5, wherein in the reaction step, the reaction temperature is 40-160 ℃; the reaction time is 6-24 hours.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010424474.4A CN111689904B (en) | 2018-06-22 | 2018-06-22 | Preparation method of triazole sulfur (selenium) ketone derivative |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810648408.8A CN109020897B (en) | 2018-06-22 | 2018-06-22 | Azole sulfur (selenium) ketone derivative and preparation method and application thereof |
| CN202010424474.4A CN111689904B (en) | 2018-06-22 | 2018-06-22 | Preparation method of triazole sulfur (selenium) ketone derivative |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810648408.8A Division CN109020897B (en) | 2018-06-22 | 2018-06-22 | Azole sulfur (selenium) ketone derivative and preparation method and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN111689904A true CN111689904A (en) | 2020-09-22 |
| CN111689904B CN111689904B (en) | 2021-06-25 |
Family
ID=64609893
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810648408.8A Active CN109020897B (en) | 2018-06-22 | 2018-06-22 | Azole sulfur (selenium) ketone derivative and preparation method and application thereof |
| CN202010424474.4A Active CN111689904B (en) | 2018-06-22 | 2018-06-22 | Preparation method of triazole sulfur (selenium) ketone derivative |
| CN202010424469.3A Active CN111606858B (en) | 2018-06-22 | 2018-06-22 | Preparation method of imidazole sulfur (selenium) ketone derivative |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810648408.8A Active CN109020897B (en) | 2018-06-22 | 2018-06-22 | Azole sulfur (selenium) ketone derivative and preparation method and application thereof |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010424469.3A Active CN111606858B (en) | 2018-06-22 | 2018-06-22 | Preparation method of imidazole sulfur (selenium) ketone derivative |
Country Status (1)
| Country | Link |
|---|---|
| CN (3) | CN109020897B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114920906A (en) * | 2022-05-23 | 2022-08-19 | 华南理工大学 | Polyurethane containing imidazole thione unit as well as preparation method and application thereof |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111978260B (en) * | 2020-07-29 | 2022-06-14 | 华南农业大学 | Benzimidazolone derivative or agriculturally and pharmaceutically acceptable salt and application thereof |
| CN114685495B (en) * | 2022-03-31 | 2023-08-04 | 华南农业大学 | N-difluoromethyl diazacyclo selenourea compound with insecticidal, bacteriostatic, herbicidal and anticancer effects and preparation and application thereof |
| CN115650926A (en) * | 2022-11-16 | 2023-01-31 | 华南农业大学 | Azole selenone functional reagent and application thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106749057A (en) * | 2016-12-30 | 2017-05-31 | 南京工业大学 | A kind of synthetic method of midbody compound and prothioconazoles |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5104993A (en) * | 1989-08-04 | 1992-04-14 | E. I. Du Pont De Nemours And Company | 1,3-dialkylimidazole-2-thione catalysts and method of making same |
| WO1994001411A1 (en) * | 1992-07-10 | 1994-01-20 | Ciba-Geigy Ag | Benzimidazole derivatives as microbicides |
| CN1088921A (en) * | 1993-01-01 | 1994-07-06 | 希巴-盖吉股份公司 | Microbicide |
| WO2013059984A1 (en) * | 2011-10-25 | 2013-05-02 | 西北农林科技大学 | Derivative of methacryloyl-benzimidazol-one (thione) and use thereof as anti-microbial drug |
| CN102503896A (en) * | 2011-10-25 | 2012-06-20 | 西北农林科技大学 | Methylacryloyl-benzimidazole (sulfur) ketone derivative and application of serving as antibacterial agent thereof |
| CN103664791A (en) * | 2012-09-12 | 2014-03-26 | 西北农林科技大学农药研究所 | Derivative of 1-acyl benzimidazolone and use thereof as agricultural fungicide |
-
2018
- 2018-06-22 CN CN201810648408.8A patent/CN109020897B/en active Active
- 2018-06-22 CN CN202010424474.4A patent/CN111689904B/en active Active
- 2018-06-22 CN CN202010424469.3A patent/CN111606858B/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106749057A (en) * | 2016-12-30 | 2017-05-31 | 南京工业大学 | A kind of synthetic method of midbody compound and prothioconazoles |
Non-Patent Citations (2)
| Title |
|---|
| JOHN R. MIECZNIKOWSKI等: "Syntheses, characterization, density functional theory calculations, and activity of tridentate SNS zinc pincer complexes based on bis-imidazole or bis-triazole precursors", 《INORGANICA CHIMICA ACTA》 * |
| JOHN R. MIECZNIKOWSKI等: "Synthesis, characterization, density functional theory calculations, and activity of a thione-containing NNN-bound zinc pincer complex based on a bis-triazole precursor", 《INORGANICA CHIMICA ACTA》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114920906A (en) * | 2022-05-23 | 2022-08-19 | 华南理工大学 | Polyurethane containing imidazole thione unit as well as preparation method and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN109020897A (en) | 2018-12-18 |
| CN111689904B (en) | 2021-06-25 |
| CN111606858A (en) | 2020-09-01 |
| CN111606858B (en) | 2021-06-25 |
| CN109020897B (en) | 2020-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111689904B (en) | Preparation method of triazole sulfur (selenium) ketone derivative | |
| Sadashiva et al. | Synthesis, structure characterization, in vitro and in silico biological evaluation of a new series of thiazole nucleus integrated with pyrazoline scaffolds | |
| Albayrak et al. | Benzimidazolium salts bearing 2-methyl-1, 4-benzodioxane group: synthesis, characterization, computational studies, in vitro antioxidant and antimicrobial activity | |
| CN111642504A (en) | Quinoline 4-hydroxypyridine formate compound and application thereof in preventing and treating rice blast germs | |
| CN111646974A (en) | N-methyl gatifloxacin propenone derivative and preparation method and application thereof | |
| CN115385917B (en) | Tryptanthrin 7-or 9-substituted aromatic thioether derivative, and preparation method and application thereof | |
| CN103772283B (en) | Pyrazole compound containing aromatic ring and dihalide substituent as well as preparation method and use thereof | |
| JPH01221371A (en) | Production of cyclic oxyamine derivative | |
| Insa et al. | synthesis, characterization and antimicrobial activities of 1, 4-disubstituted 1, 2, 3-triazole compounds | |
| CN113563281B (en) | Benzophenone compound containing 1,3, 4-thiadiazole thioether structure and application thereof | |
| CN111646937B (en) | Propenone derivative of N-acetyl ciprofloxacin and preparation method and application thereof | |
| JPS6345277A (en) | Isoxazolyethanol derivative, antimycotic agent and agricultural fungicide | |
| CN111646975B (en) | N-methyl lomefloxacin allyl ketone derivative and preparation method and application thereof | |
| CN110357891B (en) | Chromone-substituted 2-hydroxypyrrole derivative and synthesis method and application thereof | |
| NO152840B (en) | PROCEDURE FOR THE PREPARATION OF DIBENZYLETERS | |
| CN112824396A (en) | N-acetyl lomefloxacin allyl ketone derivative and preparation method and application thereof | |
| CN112824397A (en) | Lomefloxacin allyl ketone derivative and preparation method and application thereof | |
| CN114716451B (en) | Frutinone compound and preparation method and application thereof | |
| CN113234063B (en) | Pyrazolyl-asarum derivative, preparation method and application thereof | |
| CN115417879B (en) | N-pyrimidinyl cycloiminedibenzo [1,5] diazocine derivative and preparation and application thereof | |
| CN114085199B (en) | Chalcone derivative containing sulfonyl piperazine as well as preparation method and application thereof | |
| CN110878087B (en) | Shenqinmycin triazole derivative and preparation method and application thereof | |
| CN115536543B (en) | Triclosan compound containing isopropanolamine structure and preparation method and application thereof | |
| CN112851680B (en) | Indole drug molecule for medical nursing sterilization and disinfection, and preparation method and application thereof | |
| CN111646938B (en) | Propenone derivative of pefloxacin, and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |